Watch Ticker

Structure Therapeutics Inc. American Depositary Shares

Go to Structure Therapeutics Inc. American Depositary Shares Website

$16.30

-0.38 (-2.31%)

Live

Previous Close

$16.68

Day Range

$15.8 - $16.69

Previous Day Range

$16.39 - $16.95

Market Cap

$965.5 million USD

Day Vol.

420324

Previous Day Vol.

948885

Currency

USD

Primary Exchange

Nasdaq

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both struc...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

Structure Therapeutics, a clinical-stage biopharmaceutical company, announced two late-breaking poster presentations at the American Diabetes Association 85th Scientific Sessions. The presentations will include preclinical data for their oral small molecule amylin agonist, ACCG-2671, and their oral small molecule GLP-1 receptor agonist, GSBR-5595.

Related tickers: GPCR.

Read Full Article

Rich Smith - Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Pfizer announced it will discontinue development of its oral GLP-1 weight loss pill danuglipron due to the risk of liver injury. This news benefits Eli Lilly, Novo Nordisk, and Viking Therapeutics, who are now in a better position in the GLP-1 weight loss drug market.

Related tickers: PFE, LLY, NVO, VKTX, GPCR.

Read Full Article

Trending Tickers

Please sign in to view